STOCK ALARM
PRO
SA
PRO
Market
Screener
Charts
Alerts
⌘
K
LON
NYC
Crypto
Pro
Sign In
Free Account
Theravance Biopharma, Inc.
TBPH
NASDAQ
LOADING
|
|
|
Overview
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
As of
2024
• vs 2023
Annual
Quarterly
Per Share
Revenue/Share
$1.32
+26.9%
Net Income/Share
$-1.15
-15.7%
Operating CF/Share
$-0.24
+51.6%
Free CF/Share
$-0.24
+54.4%
Cash/Share
$1.81
-2.3%
Book Value/Share
$3.59
-6.7%
Tangible Book/Share
$3.59
-6.7%
Equity/Share
$3.59
-6.7%
Interest Debt/Share
$1.07
+15.1%
Valuation
Market Cap
$459.65M
-26.1%
Enterprise Value
$471.67M
-25.3%
P/E Ratio
-8.15
+27.7%
P/S Ratio
7.14
-34.0%
P/OCF Ratio
-39.85
-73.1%
P/FCF Ratio
-38.73
-83.7%
P/B Ratio
2.62
-10.3%
P/TB Ratio
2.62
-10.3%
EV/Sales
7.33
-33.4%
EV/EBITDA
-12.27
-0.4%
Profitability
Earnings Yield
-12.27%
-38.2%
FCF Yield
-2.58%
+45.6%
ROE
-32.14%
-24.0%
ROIC
-14.11%
+9.1%
Return on Tangible Assets
-15.93%
-10.3%
Capital Allocation
CapEx/OCF
-2.88%
+68.8%
CapEx/Revenue
0.52%
-88.1%
CapEx/Depreciation
0.09
-84.3%
SBC/Revenue
33.23%
-24.8%
Balance Sheet
Debt/Equity
0.28
+23.0%
Debt/Assets
0.14
+9.3%
Net Debt/EBITDA
-0.31
-68.0%
Current Ratio
5.02
-6.9%
Interest Coverage
-18.44x
+22.7%
Income Quality
0.20
-58.2%
Efficiency
Days Sales Outstanding
388 days
+249.3%
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.94x
-71.4%
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$-0.80
+17.6%